Sitagliptin for Prevention of aGVHD After Alternative Donor Transplatation

Conditions:   Acute-graft-versus-host Disease;   Allogeneic Hematopoietic Stem Cell Transplantation Interventions:   Drug: Sitagliptin + Standard Prophylaxis;   Drug: Standard Prophylaxis Sponsors:   The First Affiliated Hospital of Soochow University;   The First Affiliated Hospital with Nanjing Medical University;   The Second People's Hospital of Huai'an;   The First People's Hospital of Changzhou;   Xinqiao Hospital of Chongqing Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials